Lobbying Update: $1,150,000 of CENCORA INC. lobbying was just disclosed

Cencora Inc. (COR) disclosed $1,150,000 in lobbying expenditures for Q1 2026, targeting various legislative issues including pharmacist services, Inflation Reduction Act implementation, drug pricing, and supply chain resilience. The article also provides details on recent insider trading activity with significant sales, institutional investor movements, and current analyst ratings and price targets for COR stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin